These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 2708072
21. Hemodialysis patient regarded as a primary hyperoxaluria after long-term hemodialysis and renal transplantation. Makita Y, Yamakuma M, Matsumura T, Akiyoshi S, Inoue N. Fukuoka Igaku Zasshi; 1995 Apr; 86(4):121-5. PubMed ID: 7782024 [Abstract] [Full Text] [Related]
22. Unusual morphology of calcium oxalate calculi in primary hyperoxaluria. Daudon M, Estepa L, Lacour B, Jungers P. J Nephrol; 1998 Apr; 11 Suppl 1():51-5. PubMed ID: 9604812 [Abstract] [Full Text] [Related]
23. Preemptive liver transplantation in primary hyperoxaluria type 1: timing and preliminary results. Kemper MJ, Nolkemper D, Rogiers X, Timmermann K, Sturm E, Malago M, Broelsch CE, Burdelski M, Müller-Wiefel DE. J Nephrol; 1998 Apr; 11 Suppl 1():46-8. PubMed ID: 9604810 [Abstract] [Full Text] [Related]
24. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure. Raju DL, Cantarovich M, Brisson ML, Tchervenkov J, Lipman ML. Am J Kidney Dis; 2008 Jan; 51(1):e1-5. PubMed ID: 18155525 [Abstract] [Full Text] [Related]
25. Recurrence of oxalate deposition in a renal transplant during ciclosporin A therapy. Drachman R, Dollberg L, Drukker A. Child Nephrol Urol; 2008 Jan; 9(1-2):90-2. PubMed ID: 3075154 [Abstract] [Full Text] [Related]
26. Timing of renal transplantation in the management of pyridoxine-resistant type I primary hyperoxaluria. Watts RW, Morgan SH, Purkiss P, Mansell MA, Baker LR, Brown CB. Transplantation; 1988 Jun; 45(6):1143-5. PubMed ID: 3289157 [No Abstract] [Full Text] [Related]
27. [Primary hyperoxaluria: Tunisian experience apropos of 24 pediatric cases]. Kamoun A, Daudon M, Zghal A, Lasram L, Ben Maiz H, Belkahia C, Lakhoua R. Nephrologie; 1997 Jun; 18(2):59-64. PubMed ID: 9182235 [Abstract] [Full Text] [Related]
28. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria. Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F. Nephrol Dial Transplant; 1993 Jun; 8(12):1333-7. PubMed ID: 8159301 [Abstract] [Full Text] [Related]
29. Early and unusual presentation of type I primary hyperoxaluria. Giugliani R, Jardim L, Edelweiss MI, Rosa A. Child Nephrol Urol; 1990 Jun; 10(2):107-8. PubMed ID: 2253247 [Abstract] [Full Text] [Related]
30. [Iterative fractures in type I primary hyperoxaluria. Report of 2 cases]. Levadoux M, Picon G, Gadea J, Delarue A, Jouve JL, Bollini G. Rev Chir Orthop Reparatrice Appar Mot; 1999 Mar; 85(1):75-80. PubMed ID: 10327470 [Abstract] [Full Text] [Related]
31. Primary hyperoxaluria type 1 in Tunisian children. Gargah T, Khelil N, Gharbi Y, Karoui W, Trabelsi M, Rajhi H, Abdelmoula J, Lakhoua MR. Tunis Med; 2011 Feb; 89(2):163-7. PubMed ID: 21308625 [Abstract] [Full Text] [Related]
32. Detection of primary hyperoxaluria type 2 (L-glyceric aciduria) in patients with maintained renal function or end-stage renal failure. Marangella M, Petrarulo M, Cosseddu D, Vitale C, Cadario A, Barbos MP, Gurioli L, Linari F. Nephrol Dial Transplant; 1995 Feb; 10(8):1381-5. PubMed ID: 8538930 [Abstract] [Full Text] [Related]
33. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA. Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227 [Abstract] [Full Text] [Related]
34. Management of oxalosis. Broyer M, Jouvet P, Niaudet P, Daudon M, Revillon Y. Kidney Int Suppl; 1996 Jan; 53():S93-8. PubMed ID: 8770999 [Abstract] [Full Text] [Related]
35. Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation. Malla I, Lysy PA, Godefroid N, Smets F, Malaise J, Reding R, Sokal EM. Pediatr Transplant; 2009 Sep; 13(6):782-4. PubMed ID: 19032423 [Abstract] [Full Text] [Related]
36. Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria. Grujic D, Salido EC, Shenoy BC, Langman CB, McGrath ME, Patel RJ, Rashid A, Mandapati S, Jung CW, Margolin AL. Am J Nephrol; 2009 Sep; 29(2):86-93. PubMed ID: 18698135 [Abstract] [Full Text] [Related]